Clinical Trial Update: Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy adults shows safety and immunogenicity of a novel conjugate vaccine targeting Salmonella Typhi and Salmonella Paratyphi A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paratyphoid Fever
• Typhoid Fever

Drugs mentioned

• GSK Salmonella Typhi/Paratyphi A conjugate vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Typhoid Fever | Phase 1 | Status: COMPLETED | Results posted: 2025-01-24